Dendritic cell immunoreceptor drives atopic dermatitis by modulating oxidized CaMKII-involved mast cell activation.

As expected, ILC2 cells were clearly increased in CRE- or OVA-treated mice relative to those untreated mice ( Figure 2B ), while the increase did not reach statistical significance for CRE treatment because of the limited sample size ( P = 0.071).

also in 111,027 other papers